Cargando…
Blue Light Cystoscopy with Cysview: The USC Experience
Introduction: Blue light cystoscopy (BLC) using hexaminolevulinic acid has been shown to improve the detection of nonmuscle invasive bladder cancer (NMIBC) during transurethral resection of bladder tumors.(1–3) Although the FDA has not yet approved BLC for the detection of carcinoma in situ (CIS), b...
Autores principales: | Bazargani, Soroush T., Djaladat, Hooman, Schuckman, Anne K., Hugen, Cory M., Daneshmand, Siamak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964244/ http://dx.doi.org/10.1089/vid.2015.0054 |
Ejemplares similares
-
Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions
por: Bazargani, Soroush T., et al.
Publicado: (2018) -
The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol
por: Zainfeld, Daniel, et al.
Publicado: (2018) -
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases
por: Mitra, Anirban P., et al.
Publicado: (2022) -
Multiparametric cystoscopy: is the future here yet?
por: Ahmadi, Hamed, et al.
Publicado: (2021) -
Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center
por: Sobhani, Sina, et al.
Publicado: (2023)